Cargando…
The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287746/ http://dx.doi.org/10.1186/1745-6215-12-S1-A31 |
| _version_ | 1782224734148100096 |
|---|---|
| author | Phillips, Patrick PJ Crook, Angela Nunn, Andrew J |
| author_facet | Phillips, Patrick PJ Crook, Angela Nunn, Andrew J |
| author_sort | Phillips, Patrick PJ |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3287746 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32877462012-02-28 The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs Phillips, Patrick PJ Crook, Angela Nunn, Andrew J Trials Oral Presentation BioMed Central 2011-12-13 /pmc/articles/PMC3287746/ http://dx.doi.org/10.1186/1745-6215-12-S1-A31 Text en Copyright ©2011 Phillips et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Phillips, Patrick PJ Crook, Angela Nunn, Andrew J The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title | The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title_full | The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title_fullStr | The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title_full_unstemmed | The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title_short | The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| title_sort | evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287746/ http://dx.doi.org/10.1186/1745-6215-12-S1-A31 |
| work_keys_str_mv | AT phillipspatrickpj theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns AT crookangela theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns AT nunnandrewj theevolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns AT phillipspatrickpj evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns AT crookangela evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns AT nunnandrewj evolutionofandchallengesindefiningtheclinicalendpointintuberculosistreatmenttrialswithnoninferioritydesigns |